• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 25, 2019
Financial News

BridgeBio raises $299M to advance rare disease portfolio

Read More
BioCentury | Jan 23, 2019
Financial News

BridgeBio raises $299M to advance rare disease portfolio

Read More
BioCentury | Jun 15, 2018
Company News

BridgeBio launches rare genetic disorder subsidiary

Read More
BioCentury | Jun 15, 2018
Company News

Alexion partners with Complement, divests non-core asset

Read More
BioCentury | Jun 13, 2018
Company News

BridgeBio launches rare genetic disorder subsidiary

Read More
BioCentury | Jun 11, 2018
Company News

Alexion partners with Complement, divests non-core asset

Read More
BioCentury | Apr 20, 2018
Finance

Refilling Alexion’s cupboard

Why Wilson takeout is a smart but small step towards filling Alexion’s pipeline
Read More
BioCentury | Jul 28, 2017
Company News

Alexion announces pipeline restructuring

Read More
BioCentury | Jul 28, 2017
Company News

Alexion refocusing on complement cascade

Read More
BioCentury | May 18, 2015
Strategy

Alexion executes

How Alexion's Synageva acquisition fulfills goals of 2011 strategy
Read More
Items per page:
1 - 10 of 17